Mika Scheinin
MD, PhD, Professor Emeritus
Bioanalytics; Clinical Pharmacology; Drug Development; Positron Emission Tomography; Research Ethics
- Candida antarctica Lipase A-Based Enantiorecognition of a Highly Strained 4-Dibenzocyclooctynol (DIBO) Used for PET Imaging (2020)
- Molecules
- Effects of intramuscular vatinoxan (MK-467), co-administered with medetomidine and butorphanol, on cardiopulmonary and anaesthetic effects of intravenous ketamine in dogs (2020)
- Veterinary Anaesthesia and Analgesia
- Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α2‐adrenoceptors in mice (2020)
- Diabetes, Obesity and Metabolism
- Investigation of the effects of vatinoxan on somatic and visceral antinociceptive efficacy of medetomidine in dogs (2020)
- American Journal of Veterinary Research
- Pharmacokinetics and Sedative Effects of Intranasal Dexmedetomidine in Ambulatory Pediatric Patients (2020)
- Anesthesia and Analgesia
- Population Modelling of Dexmedetomidine Pharmacokinetics and Haemodynamic Effects After Intravenous and Subcutaneous Administration (2020)
- Clinical Pharmacokinetics
- Adrenoseptoreihin vaikuttavat lääkeaineet (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
- Adrenoseptoriagonistien farmakologiaa (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
- Adrenoseptoriantagonistit (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin
- Adrenoseptorien välittämät vaikutukset (2019) Lääketieteellinen farmakologia ja toksikologia Outi Salminen, Mika Scheinin



